KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Return on Equity (2016 - 2025)

Charles River Laboratories International (CRL) has 15 years of Return on Equity data on record, last reported at 0.04% in Q4 2025.

  • For Q4 2025, Return on Equity fell 5.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, down 5.0%, while the annual FY2025 figure was 0.04%, 5.0% down from the prior year.
  • Return on Equity reached 0.04% in Q4 2025 per CRL's latest filing, down from 0.02% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.18% in Q2 2021 and bottomed at 0.04% in Q4 2025.
  • Average Return on Equity over 5 years is 0.11%, with a median of 0.15% recorded in 2023.
  • Peak YoY movement for Return on Equity: rose 14bps in 2021, then decreased -14bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.16% in 2021, then grew by 9bps to 0.18% in 2022, then decreased by -21bps to 0.14% in 2023, then plummeted by -95bps to 0.01% in 2024, then tumbled by -721bps to 0.04% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.04% in Q4 2025, 0.02% in Q3 2025, and 0.02% in Q2 2025.